The conclusions following from all this information are that nowadays several markers have been used to improve diagnostic accuracy in the cases of uncertain or suspected cytological tests and mutation detection in clinical FNAB samples from thyroid nodules with the addition of BRAF mutation, and also the detection of RAS, RET/PTC, and PAX8/PPARγ mutations, may also contribute to cancer diagnosis. This evidence concerns the gene RET and thyroid nodule.